Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P050023/S209

BIOexpress

Biotronik, Inc. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONP050023/S209

What did the FDA approve?

On 2026-10-16, FDA recorded an approval decision for PMA supplement P050023/S209, submitted by Biotronik, Inc. under the Normal 180 Day Track. The supplement is associated with BIOexpress, described in the source as a dedicated interrogation-only device for status checks of BIOTRONIK implantable pulse generators (IPGs, CRT-Ps), implantable cardioverter defibrillators (ICDs, CRT-Ds) and implantable cardiac monitors (ICMs).

The recorded supplement reason is a change in design, components, specifications or material. That reason describes the scope of the supplement rather than a new approval of the underlying system, and the source does not identify which component or specification changed. The device category is listed as DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER, with product code MRM and Cardiovascular specialty. The source provides no documents, so the specific modification, supporting data and any labeling effect remain unknown.

Readers should not infer clinical performance, compatibility or current labeling from this record; those details would require the underlying FDA documents, which are not included here.

FDA approval order statement

BIOexpress, a dedicated interrogation-only device for status checks of BIOTRONIK implantable pulse generators (IPGs, CRT-Ps), implantable cardioverter defibrillators (ICDs, CRT-Ds) and implantable cardiac monitors (ICMs)
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Oct 16, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P050023/S209
Regulatory pathway
PMA supplement
Product code
MRM
Decision code
APPR
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER.

Product code
MRM
FDA device class
3

For the original device and its historical approval scope, see PMA P050023. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P050023 · Original PMA

    TUPOS LV/ATX & KRONOS LV-T CRT-D & COROX OWT STEROID LV PACING LEAD

  2. P050023/S209 received

    Application receipt date recorded by FDA.

  3. P050023/S211 · Related supplement

    PSW 2601.U, NEO 2601.U, Acticor Sky HF-T, Rivacor Sky HF-T, Rivacor Rise HF-T, Rivacor Aura HF-T, Acticor Sky HF-T QP, R

  4. P050023/S204 · Related supplement

    Ilivia 7 VR-T DX 404624; Intica 7 VR-T DX 404633; Intica 5 VR-T DX 404688; Ilivia 7 VR-T 404625; Intica 7 VR-T 404634; I

  5. P050023/S214 · Related supplement

    Acticor Sky HF-T, Rivacor Sky HF-T, Rivacor Rise HF-T, Rivacor Aura HF-T, Acticor Sky HF-T QP, Rivacor Sky HF-T QP, Riva

  6. P050023/S213 · Related supplement

    Acticor Sky HF-T 481986; Rivacor Sky HF-T 481991; Rivacor Rise HF-T 482017; Rivacor Aura HF-T 482013; Acticor Sky HF-T Q

  7. P050023/S215 · Related supplement

    Ilivia 7 VR-T DX DF-1 ProMRI Ilivia 7 VR-T DF-1 ProMRI Ilivia 7 VR-T DF4 ProMRI Intica 7 VR-T DX DF-1 ProMRI Intica 7 VR

  8. P050023/S209 · FDA decision

    Normal 180 Day Track

  9. P050023/S216 · Related supplement

    Ilivia 7 VRT DX, Intica 7 VRT DX, Intica 5 VRT DX, Ilivia 7 VRT, Intica 7 VRT, Intica 5 VRT, Inlexa 7 VRT, Inlexa 7 VRT

Timeline entries are records held by MedtechLedger for P050023. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P050023

Explore the linked device profile

Other records with product code MRM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records